Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Watch
Primary summary from verified readiness
- Confidence
- 76% · stale
- Computed at
- 2026-10-01T01:09:24.968132+00:00
- Claimed
- 75
- Reported
- 55
- Verified
- 35
- Gap
- +40
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Agent-assisted assessment · independently reviewed · 2026-10-01
Consider adoption for defined clinical workflows after checking the model and installed software.
- Why
- Alpha.Pro has documented clinical use and preliminary dose-reduction evidence. Specified Alpha, Pro and Prime configurations have an open recall involving unapproved brain-analysis applications.
- Next
- Check the unit against FDA recall records and confirm corrective action. Stop affected applications in patient care as instructed, and locally validate imaging protocols before expansion.
Constraints
Blockers
- Affected brain-analysis applications must not be used in patient care
- Recall correction status requires verification for each affected unit
- Independent validation is uneven across Peak, Pro and Prime
- Local protocol optimization and staff training are required
- The inspected clinical comparison is small and retrospective
- Patient-outcome improvements are not established by the inspected evaluation
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 11
- Tier 1
- 9
- Tier 2
- 2
- Tier 3
- 0
- Supports
- 4
- Contradicts
- 7
- Context
- 0
- Latest observed
- 2026-02-03
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 3
- 2026-07-19 Reading moved from watch to watch.
- 2026-09-22 Reading moved from watch to watch.
- 2026-10-01 Reading moved from watch to watch.